Skip to main content
SpringerLink
Log in

Treatment induced changes of bone density and relative risk of vertebral fracture

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Johnston C.C., Slemenda C.W., Melton L.J. Clinical use of bone densitometry. N. Engl. J. Med. 1991, 324: 1105–1109.

    Article  PubMed  Google Scholar 

  2. Spector T.D., McCloskey E.V., Doyle D.V., Kanis J.A. Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: The Chingford Study. J. Bone Miner. Res. 1993, 8: 817–822.

    Article  CAS  PubMed  Google Scholar 

  3. Grampp S., Genant H.K., Mathur A., Lang P., Jergas M., Takada M., Gluer C.C., Lu Y., Chavez M. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J. Bone Miner. Res. 1997, 12: 697–711.

    Article  CAS  PubMed  Google Scholar 

  4. Black D., Cummings S.R., Genant H.K., Nevitt M.C., Palermo L., Browner W. Axial and appendicular bone density predict fractures in older women. J. Bone Miner. Res. 1992, 7: 633–638.

    Article  CAS  PubMed  Google Scholar 

  5. WHO. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series no. 843 WHO, Geneva, 1994.

    Google Scholar 

  6. Cummings S.R., Nevitt M.C., Bowner W.S., Stone K., Fox K.M., Ensrud K.E., Cauley J., Black D., Vogt T.M. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N. Engl. J. Med. 1995, 332: 767–773.

    Article  CAS  PubMed  Google Scholar 

  7. Melton III L.J., Atkinson E.J., O’Fallon W.M., Wahner H.W., Riggs B.L. Long-term fracture prediction by bone mineral density assessed at different skeletal sites. J. Bone Miner. Res. 1993, 8: 1227–1233.

    Article  PubMed  Google Scholar 

  8. Cummings S.R., Black D.M., Nevitt M.C., Browner W., Cauley J., Ensrud K.E., Genant H.K., Palermo L., Scott J., Vogt T.M. Bone density at various sites for prediction of hip fractures. The study of Osteoporotic Fractures Research Group. Lancet 1993, 341: 72–75.

    Article  CAS  PubMed  Google Scholar 

  9. Garnero P., Hausherr E., Chapuy M.C., Marcelli C., Grandjean H., Muller C., Cormier C., Bréart G., Meunier P.J., Delmas P.D. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J. Bone Miner. Res. 1996, 11: 1531–1538.

    Article  CAS  PubMed  Google Scholar 

  10. Adami S., Kenis J.A. Assessment of involutional bone loss: methodological and conceptual problems. J. Bone Min. Res. 1995, 10: 511–517.

    Article  CAS  Google Scholar 

  11. Riggs B.L., Melton III L.J., O’Fallon W.M.. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 1996, 18: 197S–201S.

    Article  CAS  PubMed  Google Scholar 

  12. Einhorn T.A. Bone strength: the bottom line. Calcif. Tissue Int. 1992, 51: 333–339.

    Article  CAS  PubMed  Google Scholar 

  13. Parfitt A.M., Mathews C.H.E., Villaneuva A.R., Kleerekoper M., Frame B., Rao D.S. Relationship between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. J. Clin. Invest. 1983, 72: 1396–1409.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Adami S., Braga V., Squaranti R., Rossini M., Gatti D., Zamberlan N. Bone measurements in asymptomatic primary hyperparathyroidism. Bone 1998, 22: 565–570.

    Article  CAS  PubMed  Google Scholar 

  15. Wilson R.J., Rao S., Ellis B., Kleerkoper M., Parfitt A.M. Mild asympthomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann. Intern. Med. 1988, 109: 959–962.

    Article  CAS  PubMed  Google Scholar 

  16. Adachi J.D., Bensen W.G., Brown J., Hanley D., Hodsman A., Josse R., Kendler D., Lentle B., Olszynski W., Ste-Marie L., Tenehouse A., Chines A.A. Intermittent etedronate therapy to prevent corticosteroid induced osteoporosis. N. Engl. J. Med. 1997, 337: 382–387.

    Article  CAS  PubMed  Google Scholar 

  17. Saag K.G., Emkey R., Schnitzer T.J., Brown J.P., Hawkins F., Goemaere S., Thamsborg G., Liberman U.A., Delmas P.D., Malice M.P., Czachur M., Daifotis A. Alendronate for the prevention and treatment of glucocorticoid induced osteoporois. N. Engl. J. Med. 1998, 339: 292–299.

    Article  CAS  PubMed  Google Scholar 

  18. Reid D., Devogelar J.P., Hughes R., Laan R., Adami S., Sacco-Gibson N., Wenderoth D. Risedronate is effective and well tolerated in treating corticosteroid-induced osteoporosis. J. Bone Miner. Res. 1998, 12: P23.

    Google Scholar 

  19. Cooper C., Atkinson E.J., O’Fallon W.M., Melton III L.J. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J. Bone Miner. Res. 1992, 7: 221–227.

    Article  CAS  PubMed  Google Scholar 

  20. Cooper C., Shah S., Hand D.J., Adams J., Compston J., Davie M., Woolf A. Screening for osteoporosis using individual risk factors. Osteoporos. Int. 1991, 2: 48–53.

    Article  CAS  PubMed  Google Scholar 

  21. Looker A.C., Wahner H.W., Dunn W.L., Calvo M.S., Harris T.B., Heyse S.P., Johnston C.C., Lindsay Jr R. Proximal femur bone mineral levels of US adults. Osteoporos. Int. 1995, 5: 389–409.

    Article  CAS  PubMed  Google Scholar 

  22. Melton III L.J., Lane A.W., Cooper C., Eastell R., O’Fallon W.M., Riggs B.L. Prevalence and incidence of vertebral deformities. Osteoporos. Int. 1993, 3: 113–119.

    Article  PubMed  Google Scholar 

  23. Black D.M., Cummings S.R., Karpf D.B., Cauley J.A., Thompson D.E., Nevitt M.C., Bauer D.C., Genant H.K., Haskell W.L., Marcus R., Ott S.M., Torner J.C., Quandt S.A., Reiss T.F., Ensrud K.E., for the Fracture Intervention Trial Research Group. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996, 348: 1535–1541.

    Article  CAS  PubMed  Google Scholar 

  24. Cummings S.R., Black D.M., Thompson D.E., Applegate W.B., Barrett-Connor E., Musliner T.A., Palermo L., Prineas R., Rubin S.M., Scott J.C., Vogt T., Wallage R., Yates A.J., LaCroix A.Z., for the Fracture Intervention Trial Research Group. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 1998, 280: 2077–2082.

    Article  CAS  PubMed  Google Scholar 

  25. Delmas P.D. Raloxifene reduces the risk of vertebral fracture and improves lipid profiles of postmenopausal women after 3 years. Calcif. Tissue Int. 1999, 64 (Suppl 1): S6.

    Google Scholar 

  26. Ross P.D., Genant H.K., Davis J.W., Miller P.D., Wasnich R.D. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos. Int. 1993, 3: 120–126.

    Article  CAS  PubMed  Google Scholar 

  27. Chevalley T., Rizzoli R., Nydegger V., Slosman D., Rapin C.H., Michel J.P., Vasey H., Bonjour J.P. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin — D — replete elderly patients. Osteoporos. Int. 1994, 4: 245–252.

    Article  CAS  PubMed  Google Scholar 

  28. Dawson-Hughes B., Harris S.S., Krall E.A., Dallal G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N. Engl. J. Med. 1997, 337: 670–676.

    Article  CAS  PubMed  Google Scholar 

  29. Kleerekoper M., Mendlovic D.B. Sodium fluoride therapy of postmenopausal osteoporosis. Endocr. Rev. 1993, 14: 312–323.

    CAS  PubMed  Google Scholar 

  30. Pak C.Y.C., Zerwekh J.E., Antich P.P., Bell N.H., Singer F.R. Slow-release sodium fluoride in osteoporosis. Osteoporos. Int. 1996, 11: 561–564.

    CAS  Google Scholar 

  31. Riggs B.L., Hodgson S.F., O’Fallon W.M., et al. Effect of fluoride treatment on fracture rate in post menopausal women with osteoporosis. N. Engl. J. Med. 1990, 322: 802–809.

    Article  CAS  PubMed  Google Scholar 

  32. Meunier P.J., Sebert J.L., Reginster J.Y., Briancon D., Appelboom T., Netter P., Loeb G., Rouillon A., Barry S., Evreux J.C., Avouac B., Marchandise X., the FAVO Study Group. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: The FAVO Study. Osteoporos. Int. 1998, 8: 4–12.

    Article  CAS  PubMed  Google Scholar 

  33. Liberman U.A., Weiss S.R., Bröll J., Minne H.W., Quan H., Bell N.H., Rodriguez-Portales J., Downs R.W. Jr., Dequeker J., Favus M., Seeman E., Recker R., Capizzi T., Santora A.C., Lombardi A., Shah R.V., Hirsch L.J., Karpf D. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N. Engl. J. Med. 1995, 333: 1437–1443.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Riabilitazione Reumatologica, Ospedale di Valeggio, University of Verona, 37067, Valeggio, Verona, Italy

    Silvano Adami, O. Viapiana & F. Corallo

Authors
  1. Silvano Adami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Viapiana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Corallo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Silvano Adami.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adami, S., Viapiana, O. & Corallo, F. Treatment induced changes of bone density and relative risk of vertebral fracture. J Endocrinol Invest 22, 609–615 (1999). https://doi.org/10.1007/BF03343618

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343618

Key-words

Search

Navigation